Compare iShares Core MSCI Emerging Markets ETF (IEMG) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Core MSCI Emerging Markets ETF vs Nuwellis Inc — how do they compare? iShares Core MSCI Emerging Markets ETF trades at $81.11, while Nuwellis Inc trades at $1.42 (market cap $542.80K). The key difference: iShares Core MSCI Emerging Markets ETF is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| IEMG | NUWE | |
|---|---|---|
Sector | Broad Market / Factor | Technology |
52-Week High | $86.00 | $220.50 |
52-Week Low | $61.76 | $1.42 |
Market Cap | — | $542.80K |
Enterprise Value | — | -$1.27M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IEMG trades at $80.97, up 1.77% with a bullish technical signal from moving averages. The ETF offers emerging markets exposure with a 0.09% expense ratio and significant technology weighting. Recent performance shows strong returns but elevated volatility compared to developed market alternatives.
The outlook remains positive given attractive valuations and growth potential in emerging markets, though concentration in tech/AI stocks and geopolitical risks warrant monitoring. Current technical indicators show potential resistance near $81 with support at $79-80 levels.
NUWE trades at $1.41, down 0.7% on the day, with a bearish technical signal driven by moving averages. The company shows strong revenue growth, with preliminary Q2 2026 revenue up 14% year-over-year, but remains unprofitable with a net income margin of -217.22%. Recent developments include a reverse stock split, new CEO appointment, and expansion of its Aquadex platform into new pediatric markets. Cash flow from operations is negative, though recent financing activities have provided capital.
The outlook is mixed: growth initiatives and analyst support offer potential, but persistent losses and high cash burn pose significant risks. Investors should weigh the company's expansion against its financial sustainability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares Core MSCI Emerging Markets ETF
IEMG tracks the MSCI Emerging Markets Investable Market Index, providing broad exposure to large, mid, and small-cap stocks across over 20 emerging market countries. It is designed as a low-cost core holding for investors seeking diversified growth from economies outside of developed markets.
Read more on IEMG →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
